Biosight Ltd.

Biosight Ltd.

Biosight is a private Phase 2 clinical stage biotech company developing innovative therapeutics for hematological malignancies and disorders. Biosight’s lead product, BST-236 (aspacytarabine), is an i...

Biosight Ltd.'s Basic Information

Industry
Pharmaceutical Manufacturing
Headquarters
Israel
Founded Year
2000
Headcount
2 - 10
Specialties
Pharmaceutical developmentPro-drugsLeukemia treatmentNon-toxic chemotherapyTargeted chemotherapyBiotechnologyAcute myeloid leukemia (AML)myelodysplastic syndrome

Biosight Ltd.'s Competitors

ASCENT PHARMACEUTICALS, INC.
ASCENT PHARMACEUTICALS, INC.

Central Islip, New York, United States

Anabond Stedman Pharma Research (P) LTD
Anabond Stedman Pharma Research (P) LTD

Pharmasense
Pharmasense

Greece

Zen Intelligence
Zen Intelligence

mühlberger gmbh
mühlberger gmbh

Employee Insights

Employee Function

Employee Location

Biosight Ltd.'s Top Employees

people
Roy Golan
Executive Vice President & CFO
people
Darrel Cohen
Chief Medical Officer
people
Adva Spector
Executive Assistant TO Chief Executive Officer
people
Shoshi Tessler
VP R&D
people
Liat Flaishon
VP Medical Affairs

Find Your Next Customer with Better Data

Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.

Top-ranked on G2 Crowd
🛡️GDPR compliantCancel anytime
Free credits every month!

Frequently Asked Questions Regarding Biosight Ltd.

Where is Biosight Ltd.'s headquarter located?

Biosight Ltd.'s headquarter are located at Israel.

How many employees does Biosight Ltd. have?

Biosight Ltd. has 2 - 10 employees.

What is Biosight Ltd.'s official website?

Biosight Ltd.'s official website is http://biosight-pharma.com

What industry does Biosight Ltd. belong to?

Biosight Ltd. is in the industry of Pharmaceutical Manufacturing

What does Biosight Ltd. do?

Biosight is a private Phase 2 clinical stage biotech company developing innovative therapeutics for hematological malignancies and disorders. Biosight’s lead product, BST-236 (aspacytarabine), is an i...

What specialty does Biosight Ltd. have?

Pharmaceutical developmentPro-drugsLeukemia treatmentNon-toxic chemotherapyTargeted chemotherapyBiotechnologyAcute myeloid leukemia (AML)myelodysplastic syndrome

Connect with anyone with AroundDeal today!

Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
cta